Why we should attempt to eliminate (Silent and Symptomatic) ischemia in patients with chronic stable angina

Clinical Cardiology

Volumn 21, Issue 12 SUPPL. 2, 1998, Pages

  Conti, C Richard ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angina; Silent ischemia; Treatment

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANGINA PECTORIS; CONFERENCE PAPER; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; HUMAN; ST SEGMENT; TREATMENT PLANNING;

ANGINA PECTORIS; CHRONIC DISEASE; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS;

EID: 3743064920     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Quyyumi AA, Mockus L, Wright C, Fox KM: Morphology of ambulatory ST-segment changes in patients with varying severity of coronary artery disease. Investigation of the frequency of nocturnal ischaemia and coronary spasm. Br Heart J 1985;53:186-193
2. Quyyumi AA, Wright C, Fox K: Ambulatory electrocardiographic ST-segment changes in healthy volunteers. Br Heart J 1983;50: 460-464
3. Armstrong WF, Jordan JW, Morris SN, McHenry PL: Prevalence and magnitude of S-T segment and T wave abnormalities in normal men during continuous ambulatory electrocardiography. Am J Cardiol 1982;49:1638-1642
4. Balasubramanian V, Lahiri A, Green HL, Stott FD, Raftery EB: Ambulatory ST segment monitoring. Problems, pitfalls, solutions, and clinical application. Br Heart J 1980;44:419-425
5. Crawford MH, Mendoza CA, O'Rourke RA, White DH, Boucher CA, Gorwit J: Limitations of continuous ambulatory electrocardiogram monitoring for detecting coronary artery disease. Ann Intern Med 1978;89:1-5
6. Stern S, Tzivoni D, Stern Z: Diagnostic accuracy of ambulatory ECG monitoring in ischemic heart disease. Circulation 1975;52: 1045-1049
7. Stern S, Tzivoni D: Early detection of silent ischaemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br Heart J 1974;36:481-486
8. Bellet S, Roman L, Kostis J, Slater A: Continuous electrocardiographic monitoring during automobile driving. Studies in normal subjects and patients with coronary disease. Am J Cardiol 1968;22: 856-862
9. Lachman AB, Semler HJ, Gustafson RH: Postural ST-T wave changes in the radioelectrocardiogram simulating myocardial ischemia. Circulation 1965;31:557-563
10. Klein J, Rodrigues EA, Berman DS, Prigent F, Chao SY, Maryon T, Rozanski A: Prevalence and functional significance of transient ST-segment depression during daily life activity: Comparisons of ambulatory ECG with stress redistribution thallium 201 single-photon emission computed tomographic imaging. Am Heart J 1993;125(5 Pt 1):1247-1257
11. Deedwania PC: Silent ischaemia: To treat or not to treat? Indian Heart J 1996;48:415-419
12. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U, for the ASIST Study Group: Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994;90:762-768
13. Deedwania PC, Carbajal E, Nelson J. Spears K: Antianginal therapy directed towards symptom control does not abolish silent ischemic events (abstr). J Am Coll Cardiol 1988;2:47A
14. Deanfield JE, Shea M, Ribiero P, de Landsheere CM, Wilson RA, Horlock P, Selwyn AP: Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol 1984;54:1195-1200
15. Deanfield JE, Selwyn AP, Chierchia S, Maseri A, Ribeiro P, Krikler S, Morgan M: Myocardial ischemia during daily life in patients with stable angina: Its relation to symptoms and heart rate changes. Lancet 1983;2:753-758
16. Maseri A: Pathogenetic mechanisms of angina pectoris: Expanding views. Br Heart J 1980;43:648-660
17. Schang SJ, Pepine CJ: Transient asymptomatic S-T segment depression during daily activity. Am J Cardiol 1977;39:396-402
18. Talbert RL: Ischemic heart disease. In Pharmacotherapy: A Pathophysiologic Approach, third ed., (Ed. DiPiro JT), p. 257-294. Stamford, Conn.: Appleton & Lange, 1997
19. Weiner DA, Ryan TJ, Mccabe CH, Luks S, Chaitman BR, Sheffield LT, Tristani F, Fisher LD: Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. Am J Cardiol 1987;59:725-729
20. Bonow RO, Bacharach SL, Green MV, LaFreniere RL, Epstein SE: Prognostic implications of symptomatic versus asymptomatic (silent) myocardial ischemia induced by exercise in mildly symptomatic and in asymptomatic patients with angiographically documented coronary artery disease. Am J Cardiol 1987;60(10): 778-783
21. Deedwania PC: Silent myocardial ischemia and its relationship to acute myocardial infarction. Cardiol Clin 1986;4:643-658
22. Deedwania PC, Carbajal EV: Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990;81:748-756
23. Braun S, vander Wall EE, Emanuelsson H, Kobrin I: Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable angina pectoris: A multicenter placebo-controlled study. The Mibefradil International Study Group. J Am Coll Cardiol 1996;27:317-322
24. Tzivoni D, Medina A, David D, Barzilai Y, Gavish A, Shatboon D, Keren A, Brunel P: Comparison between metoprolol orally osmotic once daily and metoprolol two or three times daily in suppressing exercise-induced and daily myocardial ischemia. Am J Cardiol 1996;78:1362-1368
25. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, Forman SA, Geller NL, Goldberg AD, Habib GB, Masters RG, Moisa RB, Mueller H, Pearce DJ, Pepine CJ, Sopko G, Steingart RM, Stone PH, Knatterud GL, Conti CR, for the ACIP Investigators: Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 1995;26(3):594-605
26. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, Sopko G, Pratt C, Deanfield J, Conti CR, for the ACIP Investigators: Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up. Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95(8):2037-2043
27. Ruberman W, Crow R, Rosenberg CR, Rautaharju PM, Shore RE, Pasternack BS: Intermittent ST depression and mortality after myocardial infarction. Circulation 1992;85:1440-1446
28. Knatterud GL, Bourassa MG, Pepine CJ, Geller NL, Sopko G, Chaitman BR, Pratt C, Stone PH, Davies RF, Rogers WJ, Deanfield JE, Goldberg AD, Ouyang P, Mueller H, Sharaf B, Day P, Selwyn AP, Conti CR, for the ACIP Investigators: Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol 1994;24:11-20
29. van Boven AJ, Jukema W, Zwinderman AH, Crijns HJ, Lie KI, Bruschke AV: Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. Circulation 1996;94:1503-1505
30. Sacks FM, Pfeffer MA, Moyé LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009
31. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389
32. Rapaport E, Gheorghiade M: Pharmacologic therapies after myocardial infarction. Am J Med 1996;101(suppl 4A):61S-70S
33. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-786